Sinopharm Group Co., Ltd. Stock Shanghai - Hong Kong Stock Connect
Equities
1099
CNE100000FN7
Pharmaceuticals
Sales 2024 * | 649B 89.62B 700B | Sales 2025 * | 707B 97.61B 763B | Capitalization | 56.12B 7.75B 60.56B |
---|---|---|---|---|---|
Net income 2024 * | 9.61B 1.33B 10.37B | Net income 2025 * | 10.58B 1.46B 11.42B | EV / Sales 2024 * | 0.1 x |
Net Debt 2024 * | 11.49B 1.59B 12.4B | Net Debt 2025 * | 9.36B 1.29B 10.1B | EV / Sales 2025 * | 0.09 x |
P/E ratio 2024 * |
5.83
x | P/E ratio 2025 * |
5.3
x | Employees | - |
Yield 2024 * |
5.19% | Yield 2025 * |
5.71% | Free-Float | 42.99% |
Managers | Title | Age | Since |
---|---|---|---|
Yong Liu
PSD | President | 55 | 09-01-08 |
Shuang Jun Xu
PRN | Corporate Officer/Principal | 55 | 11-02-28 |
Zhong Xi Cai
PRN | Corporate Officer/Principal | 59 | 10-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Qi Yu Chen
BRD | Director/Board Member | 52 | 10-04-30 |
Xiao Hui Guan
BRD | Director/Board Member | 53 | 19-01-10 |
Yi Jian Wu
SEC | Corporate Secretary | 54 | - |
1st Jan change | Capi. | |
---|---|---|
+14.53% | 69.68B | |
+7.11% | 8.21B | |
-20.55% | 7.96B | |
+2.32% | 4.64B | |
+17.12% | 4.32B | |
-1.24% | 4.09B | |
-3.78% | 3.82B | |
+21.42% | 3.62B | |
+8.64% | 3.39B |